XML 18 R5.htm IDEA: XBRL DOCUMENT v3.24.0.1
CONDENSED CONSOLIDATED STATEMENTS OF STOCKHOLDERS' EQUITY (Unaudited) - USD ($)
Common Shares
Additional Paid in Capital
Accumulated Deficit
Noncontrolling Interest
Total
Beginning Balance at Sep. 30, 2022 $ 12,909 $ 305,399,008 $ (292,500,088) $ (2,890) $ 12,908,939
Beginning Balance (in shares) at Sep. 30, 2022 12,908,520        
Increase (Decrease) in Stockholders' Equity          
Stock based compensation expense   93,748     93,748
Net loss     (3,843,372) (874) (3,844,246)
Ending Balance at Dec. 31, 2022 $ 12,909 305,492,756 (296,343,460) (3,764) 9,158,441
Ending Balance (in shares) at Dec. 31, 2022 12,908,520        
Beginning Balance at Sep. 30, 2023 $ 13,659 307,384,647 (302,447,147) (78,747) $ 4,872,412
Beginning Balance (in shares) at Sep. 30, 2023 13,658,520       13,658,520
Increase (Decrease) in Stockholders' Equity          
Stock based compensation expense   340,705     $ 340,705
Common stock issued in ATM, net of offering costs $ (61) (45,505)     $ (45,566)
Common stock issued in ATM, net of offering costs (In shares) 61,200       61,200
Exercise of options cashlessly $ 2 (2)      
Exercise of options cashlessly (in shares) 2,100        
Deemed dividend - warrant repricing   77,757 (77,757)    
Net loss     (1,105,100) (25,181) $ (1,130,281)
Ending Balance at Dec. 31, 2023 $ 13,722 $ 307,848,612 $ (303,630,004) $ (103,928) $ 4,128,402
Ending Balance (in shares) at Dec. 31, 2023 13,721,820       13,658,520